Physician profile
Eric Zamora
NPI 1659000123
$354.68
in general payments reported to CMS, 2019-2025
9 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.97 · 2023: $52.70 · 2024: $116 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $88.53 | 2024-2025 | Mounjaro, Zepbound |
| Abiomed | $52.26 | 2025 | |
| Viiv Healthcare Company | $51.55 | 2023-2024 | Apretude, Dovato |
| Organon LLC | $43.29 | 2022-2025 | Nexplanon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.57 | 2024-2025 | Jardiance |
| Astellas Pharma US INC | $29.71 | 2025 | Veozah |
| Dynavax Technologies Corporation | $26.05 | 2024 | Heplisav-B |
| Shield Therapeutics INC | $17.67 | 2025 | |
| Abbvie INC. | $15.05 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Zamora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.